CONTROL OF O-GLYCAN SYNTHESIS - SPECIFICITY AND INHIBITION OF O-GLYCAN CORE-1 UDP-GALACTOSE-N-ACETYLGALACTOSAMINE-ALPHA-R BETA-3-GALACTOSYLTRANSFERASE FROM RAT-LIVER

被引:34
|
作者
BROCKHAUSEN, I
MOLLER, G
POLLEXKRUGER, A
RUTZ, V
PAULSEN, H
MATTA, KL
机构
[1] UNIV TORONTO, DEPT BIOCHEM, TORONTO M5S 1A8, ONTARIO, CANADA
[2] UNIV HAMBURG, INST ORGAN CHEM, W-2000 HAMBURG 13, GERMANY
[3] NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, DEPT GYNECOL ONCOL, BUFFALO, NY 14263 USA
关键词
BETA-3-GAL-TRANSFERASE; MUCIN SYNTHESIS; O-GLYCAN CORE-1; ENZYME SPECIFICITY; ENZYME INHIBITION;
D O I
10.1139/o92-015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The specificity of glycosyltransferases is a major control factor in the biosynthesis of O-glycans. The enzyme that synthesizes O-glycan core 1, i.e., UDP-galactose: N-acetylgalactosamine-alpha-R beta-3-galactosyltransferase (beta-3-Gal-T; EC 2.4.1.122), was partially purified from rat liver. The enzyme preparation, free of pyrophosphatases, beta-4-galactosyltransferase, beta-galactosidase, and N-acetylglucosaminyltransferase I, was used to study the specificity and inhibition of the beta-3-Gal-T. Beta-3-Gal-T activity is sensitive to changes in the R-group of the GalNAc-alpha-R acceptor substrate and is stimulated when the R-group is a peptide or an aromatic group. Derivatives of GalNAc-alpha-benzyl were synthesized and tested as potential substrates and inhibitors. Removal or substitution of the 3-hydroxyl or removal of the 4-hydroxyl of GalNAc abolished beta-3-Gal-T activity. Compounds with modifications of the 3- or 4-hydroxyl of GalNAc-alpha-benzyl did not show significant inhibition. Removal or substitution of the 6-hydroxyl of GalNAc reduced activity slightly and these derivatives acted as competitive substrates. Derivatives with epoxide groups attached to the 6-position of GalNAc acted as substrates and not as inhibitors, with the exception of the photosensitive 6-O-(4,4-azo)pentyl-GalNAc-alpha-benzyl, which inhibited Gal incorporation into GalNAc-alpha-benzyl. The results indicate that the enzyme does not require the 6-hydroxyl of GalNAc, but needs the 3- and the axial 4-hydroxyl as essential requirements for binding and activity. In the usual biochemical O-glycan pathway, core 2 (GlcNAc-beta-6[Gal-beta-3]GalNAc-alpha-) is formed from core 1 (Gal-beta-3GalNAc-R). We have now demonstrated an alternate pathway that may be of importance in human tissues.
引用
收藏
页码:99 / 108
页数:10
相关论文
共 11 条